JPM Stock Sinks on JPMorgan CEO Jamie Dimon’s Throat Cancer News

Dimon said that his cancer is curable

   

JPM Stock Sinks on JPMorgan CEO Jamie Dimon’s Throat Cancer News

News of JPMorgan (JPM) CEO Jamie Dimon being diagnosed with throat cancer sent JPM stock down Wednesday afternoon.

JPMorgan185 JPM Stock Sinks on JPMorgan CEO Jamie Dimons Throat Cancer NewsDimon wrote a letter to employees following the news, writing that his cancer is curable and doctors gave him a good prognosis. Tests revealed that the cancer is no the right side of his neck and an adjacent lymph but it has not expanded to other parts of his body.

Doctors have yet to set a definite treatment schedule for the JPMorgan CEO but he will receive radiation and chemotherapy for eight weeks. Dimon will be treated at Memorial Sloan-Kettering Cancer Center in New York city.

“While the treatment will curtail my travel during this period, I have been advised that I will be able to continue to be actively involved in our business, and we will continue to run the company as normal,” he wrote. “Our Board has been fully briefed and is totally supportive.”

JPM stock is down over 1% Wednesday afternoon.

More CEOs in the News:


Article printed from InvestorPlace Media, http://investorplace.com/2014/07/jpm-stock-jpmorgan-jamie-dimon/.

©2014 InvestorPlace Media, LLC

Comments are currently unavailable. Please check back soon.